Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction

Author： Rumbaugh Jeffrey A Steiner Joseph Sacktor Ned Nath Avindra

ISSN： 1746-9600

Source： Future HIV Therapy, Vol.2, Iss.3, 2008-05, pp. : 271-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnosis and treatment of HIV-associated nephropathy

By Betjes M.G.H. Weening J. Krediet R.T.

The Netherlands Journal of Medicine, Vol. 59, Iss. 3, 2001-09 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder

By Gandhi Nishiena S Moxley Richard T Creighton Jason Roosa Heidi Vornbrock Skolasky Richard L Selnes Ola A McArthur Justin Sacktor Ned

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 371-379

Future Medicine

Access to resources Recommend Favorite

HIV-1 Subtypes B and C Tat Differentially Impact Synaptic Plasticity Expression and Implicates HIV-Associated Neurocognitive Disorders§

Current HIV Research, Vol. 12, Iss. 6, 2014-12 ,pp. : 397-405

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of HIV-1 Tat Neurotoxicity via CDK5 Translocation and Hyper-Activation: Role in HIV-Associated Neurocognitive Disorders

Current HIV Research, Vol. 13, Iss. 1, 2015-01 ,pp. : 43-54

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy

By Antoniou Tony Raboud Janet Kovacs Colin Diong Christina Brunetta Jason Smith Graham Halpenny Roberta Beninger Francis Loutfy Mona

AIDS Care, Vol. 21, Iss. 10, 2009-10 ,pp. : 1247-1252

Routledge Ltd

Access to resources Recommend Favorite